1. J&J CEO Pay Irks Investors Upset with Opioid Lawsuits Fallout

    J&J CEO Pay Irks Investors Upset with Opioid Lawsuits Fallout

    (Reuters) - Johnson & Johnson is coming under fire from some investors who are raising questions about companies that give their chief executives hefty pay raises despite facing billions of dollars in legal costs over their role in the U.S. opioid crisis. J&J has always excluded certain one-time costs such as litigation expenses from its calculation of stock payouts to executives, an approach that compensation consultants say is common across corporate America...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. A company of this size, facing a settlement of this magnitude, will manage (the cost of it) in such a way that there will not be an impact on investors.
    2. We will also look at how the incentive pay was decided on and how it rings true with the penalties they had to pay.
  3. Topics Mentioned